Published in J Hepatol on March 01, 1990
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr (2011) 1.12
Fatal anticonvulsant hypersensitivity syndrome in an infant. Eur J Pediatr (2003) 0.75
Two Cases of Thromboembolic Disease Associated with Oral Contraceptives. Br Med J (1962) 4.49
Modification in the xylose absorption test as an index of intestinal function. Gut (1967) 3.47
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet (1993) 3.41
Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet (1995) 3.31
Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vision Res (2007) 2.29
Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics (1989) 2.21
Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr Infect Dis J (1987) 2.20
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest (1988) 2.17
Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97
Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. A study of technical and metabolic features. Gastroenterology (1973) 1.87
Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation (1988) 1.78
Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol (1998) 1.77
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med (1986) 1.76
Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. A model for the study of plasma protein synthesis. Biochem J (1975) 1.66
Ia-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy (1989) 1.64
Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A (2001) 1.63
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
The evolutionary history of the extinct ratite moa and New Zealand Neogene paleogeography. Proc Natl Acad Sci U S A (2009) 1.50
Ultrastructural hepatocellular alterations induced by in vivo fructose infusion. Lab Invest (1970) 1.46
Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46
Clinical spectrum of the Budd-Chiari syndrome and its surgical management. Am J Surg (1975) 1.42
Ultrastructure of bile canaliculi, with special reference to the surface coat and the pericanalicular web. Lab Invest (1974) 1.39
Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite. Proc Natl Acad Sci U S A (1981) 1.38
Obstetricians' and gynecologists' beliefs and preferred modes of treatment for women diagnosed with premenstrual symptoms. Womens Health Issues (1992) 1.38
A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther (1987) 1.37
Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol (1996) 1.36
Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther (1980) 1.34
Contractility of bile canaliculi: implications for liver function. Science (1981) 1.31
Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med (1981) 1.29
Incidence of leukaemia in young people in the vicinity of Hinkley Point nuclear power station, 1959-86. BMJ (1989) 1.29
Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. Ann Intern Med (1989) 1.28
N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos (1995) 1.24
Four new avian mitochondrial genomes help get to basic evolutionary questions in the late cretaceous. Mol Biol Evol (2004) 1.24
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Cancer (1983) 1.23
The changing pattern of venous thromboembolic disease. Haemostasis (1997) 1.23
Severe hepatic Wilson's disease in preschool-aged children. J Pediatr (2000) 1.22
Histogenesis of salivary gland pleomorphic adenoma (mixed tumor) with an evaluation of the role of the myoepithelial cell. Hum Pathol (1982) 1.22
Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. J Antimicrob Chemother (1994) 1.20
Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics (1990) 1.20
Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg (1997) 1.18
Fibreoptic bronchoscopy and diagnosis of pulmonary lesions in lymphoma and leukaemia. Thorax (1980) 1.18
Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol (2000) 1.18
Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab Dispos (1992) 1.17
Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro. Blood (1983) 1.17
In vitro evaluation of a toxic metabolite of sulfadiazine. Can J Physiol Pharmacol (1985) 1.17
A selection of candidate compounds for in vitro teratogenesis test validation. Teratog Carcinog Mutagen (1983) 1.17
Use of lidocaine-prilocaine cream for vaccination pain in infants. J Pediatr (1994) 1.17
Controlled study of respiratory viruses and wheezing. Arch Dis Child (2002) 1.15
Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med (1992) 1.15
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15
Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography. Eur Respir J (2009) 1.13
Glycogen depletion in the newborn rat liver: an electron microscopic and electron histochemical study. J Ultrastruct Res (1967) 1.13
Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology (1975) 1.13
Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther (1991) 1.13
Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol (2000) 1.13
Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev (1996) 1.12
Modern aspects of the morphology of viral hepatitis. Hum Pathol (1981) 1.12
Genetic predisposition to phenytoin-induced birth defects. Lancet (1985) 1.09
Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol (1999) 1.09
Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies. Am J Pathol (1987) 1.09
Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol (1997) 1.08
Byler's disease: fatal intrahepatic cholestasis. J Pediatr (1972) 1.08
Ultrastructural and subcellular pathology of the liver. Int Rev Exp Pathol (1964) 1.07
Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med (1979) 1.06
Pathogenesis of fructose hepatotoxicity. Lab Invest (1974) 1.06
Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther (1992) 1.05
Use of a microplate reader in an assay of glutathione reductase using 5,5'-dithiobis(2-nitrobenzoic acid). Anal Biochem (1989) 1.05
Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology. Hepatology (2000) 1.05
Plasma histamine in asthmatic and control subjects following exercise: influence of circulating basophils and different assay techniques. Thorax (1983) 1.05
A study of bile canalicular contractions in isolated hepatocytes. Hepatology (1983) 1.04
Bendectin: the wrong way to regulate drug availability. Can Med Assoc J (1983) 1.04
Hepatic disease in erythropoietic protoporphyria. Am J Med (1975) 1.04
Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. Gastroenterology (1984) 1.04
The acute effect of ethanol on albumin, fibrinogen and transferrin synthesis in the rat. Biochem J (1972) 1.04
The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations. Virchows Arch A Pathol Anat Histopathol (1983) 1.03
Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol Pharmacol (1990) 1.03
Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery (1980) 1.03
Meeting the food and nutrition needs of the poor: the role of fish and the opportunities and challenges emerging from the rise of aquaculture. J Fish Biol (2013) 1.03
Benign liver cell tumors. Classification and ultrastructural pathology. Cancer (1973) 1.02
Cellular transplantation in the treatment of experimental hepatic failure. Science (1980) 1.01
A comparison of the in vivo effects of ketotifen, clemastine, chlorpheniramine and sodium cromoglycate on histamine and allergen induced weals in human skin. Br J Clin Pharmacol (1983) 1.01
Characterization of rat liver cell plasma membranes. Proc Soc Exp Biol Med (1975) 1.01
The structure and organization of the bile canalicular cytoskeleton with special reference to actin and actin-binding proteins. Hepatology (1995) 1.01
Multiple sclerosis, dental caries and fillings: a case-control study. Br Dent J (1999) 1.01
Managing obstruction of the central airways. Intern Med J (2009) 1.01
Normal amino acid uptake by cultured human fibroblasts does not require gamma-glutamyl transpeptidase. Biochem Biophys Res Commun (1976) 1.01
Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res (2013) 1.00
Strain field measurements on mouse carotid arteries using microscopic three-dimensional digital image correlation. J Biomed Mater Res A (2008) 1.00
Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J Pharmacol Exp Ther (1988) 1.00
Biochemical heterogeneity in glutathione synthetase deficiency. J Clin Invest (1978) 0.99
The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem (1999) 0.99
Pleuropulmonary morbidity: internal thoracic artery versus saphenous vein graft. Ann Thorac Surg (1990) 0.98
Use of anterior rhinometry in nasal provocation challenges with allergen and evaluation of the effects of ketotifen, clemastine and sodium cromoglycate on these responses. Respiration (1980) 0.98
Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics (1987) 0.98
IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells. J Immunol (1983) 0.97
Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet (1967) 0.97
Liver cell plasma membrane lipids and the origin of biliary phospholipid. Can J Biochem (1975) 0.97
Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin. Lab Invest (1983) 0.97
Familial occurrence of hypersensitivity to phenytoin. Am J Med (1991) 0.96
Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther (1992) 0.96